Bristol-Myers Squibb to Buy Celgene for $74 Billion
Bristol-Myers Squibb to Buy Celgene for $74 Billion
The deal between the two biopharmaceutical giants will boost the purchaser’s cancer drug portfolio.
Bristol-Myers Squibb to Buy Celgene for $74 Billion
Bristol-Myers Squibb to Buy Celgene for $74 Billion

The deal between the two biopharmaceutical giants will boost the purchaser’s cancer drug portfolio.

The deal between the two biopharmaceutical giants will boost the purchaser’s cancer drug portfolio.

drug
Infographic: How Exposure to Cannabis in Utero Affects Development
Infographic: How Exposure to Cannabis in Utero Affects Development
Andrew Scheyer | Jan 1, 2019
Rodent and human studies have revealed a multitude of effects starting during gestation and lasting into adulthood.
Octopuses On Ecstasy Reveal Commonalities with Humans
Octopuses On Ecstasy Reveal Commonalities with Humans
Shawna Williams | Sep 21, 2018
Just as in people, the drug stimulates the animals to behave more socially.
Novartis and Sanofi Stockpile Meds in Preparation for Brexit
Novartis and Sanofi Stockpile Meds in Preparation for Brexit
Ashley Yeager | Aug 3, 2018
If the UK leaves the EU in March without a deal, transport of insulin and other essential drugs could be delayed.
UK to Legalize Medicinal Cannabis
UK to Legalize Medicinal Cannabis
Catherine Offord | Jul 27, 2018
Patients will be able to access the drug with a prescription, and there are no plans to allow for recreational use.
Antibody-Drug Combo Approved
Antibody-Drug Combo Approved
Dan Cossins | Feb 25, 2013
The FDA approves an antibody-drug conjugate that effectively treats a certain type of advanced breast cancer with fewer side effects than previous drugs.
Comment on New NIH Center
Megan Scudellari | Feb 10, 2012
Input lines are open for the National Institute of Substance Use and Addiction Disorders.
Novel Cystic Fibrosis Drug Approved
Megan Scudellari | Feb 1, 2012
After a lightning-fast approval, the first medicine to treat an underlying cause of the disorder hits the market.
Drug Headlines of 2011
Hannah Waters | Dec 20, 2011
A list of this year’s newsworthy successes—and failures—in drug development
Lipitor Patent Expires
Cristina Luiggi | Nov 30, 2011
The pharmaceutical darling that has brought billions in revenue to Pfizer over the past 15 years will now share the shelves with its generic competitors.